MedPath

Setam

Brand Name: Setam

Generic Name: Levetiracetam

Active
Registration Number

DR-XY48015

Dosage Form

Solution for Injection (I.V. Infusion)

Issuance Date

May 16, 2022

Expiry Date

May 16, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mg/mL (500 mg/5 mL)
Packaging5 mL (net content) USP Type I clear and colorless glass vial with gray elastic rubber stopper and aluminum seal with plastic flip-off cap (box of 5 vials and 10 vials)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

LevetiracetamActive
Monograph: Levetiracetam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform